×
-0.000131371518654823 -0.000656857593273741 -0.000131371518654823 0.000788229111928564 0 0.0014450867052023 0.00223331581713087 0.0023646873357855
Stockreport

Germany's CureVac wins new vaccine funding from Gates Foundation [Reuters (UK)]

ELI LILLY (LLY)  More Company Research Source: Reuters
Last eli lilly earnings: 7/24 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Germany's CureVac wins new vaccine funding from Gates Foundation | Reuters Reuters Staff 2 Min Read (Reuters) - German biotech firm CureVac has secured more financial backing for vaccine development projects from its investor the Bill & Melinda Gates Foundation, working on jabs to prevent malaria and influenza. The research projects will run until 2020 with the aim to find drug candidates based on CureVac’s synthetic messenger RNA, or mRNA technology, that may at later stages be tested on humans, said a spokesman, declining to disclose financial terms. Drugs or vaccines based on mRNA provide a type of genetic blueprint that can be injected into the body to instruct cells to produce out the desired therapeutic proteins, as opposed to the conventional approach of making these proteins in labs and bio-reactors. “Successfully exploring the potential of the mRNA platform for development of a universal flu vaccine would be a consequential achievement, benefiting much of the world’s populati [Read more]

IMPACT SNAPSHOT EVENT TIME: LLY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
LLY alerts
from News Quantified
Opt-in for
LLY alerts

from News Quantified
Opt-in for
LLY alerts

from News Quantified